A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2011
10/13/2011	US20110250281 Fexofenadine Microcapsules and Compositions Containing Them
10/13/2011	US20110250280 Microencapsulation process of sertoli cells, microcapsules obtained and their use for prevention and cure of type i diabetes mellitus
10/13/2011	US20110250279 Controlled-release composition for producing sustained-release preparation containing udenafil
10/13/2011	US20110250278 Particles containing an opioid receptor antagonist and methods of use
10/13/2011	US20110250277 Modified release compositions comprising tacrolimus
10/13/2011	US20110250276 Cosmetic Composition Containing Acetylated Oligoglucuronans
10/13/2011	US20110250275 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans
10/13/2011	US20110250274 Estriol formulations
10/13/2011	US20110250273 Compositions of proton pump inhibitors, kits and methods of their use to treat diabetes
10/13/2011	US20110250272 Solid, orodispersible and/or dispersible composition, without an excipient of known effect and its process of preparation
10/13/2011	US20110250271 Spaced drug delivery system
10/13/2011	US20110250270 Compositions containing a capillary-active system with application-relevant diffferentiability and their use
10/13/2011	US20110250269 Highly efficient and long-acting slow-release formulation of poorly soluble drugs and preparation method thereof
10/13/2011	US20110250268 Compositions and Methods for Inhibiting Gastric Acid Secretion
10/13/2011	US20110250267 Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associated conditions
10/13/2011	US20110250266 Liposomal systems comprising sphingomyelin
10/13/2011	US20110250265 Vaccine Preparation for Neospora Caninum Infection
10/13/2011	US20110250264 Method for formulating large diameter synthetic membrane vesicles
10/13/2011	US20110250263 Protein and nucleic acid delivery vehicles, components and mechanisms thereof
10/13/2011	US20110250262 Method for producing liposome and method for dissolving cholesterol
10/13/2011	US20110250261 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
10/13/2011	US20110250260 Inhibition of brain enzymes inolved in cerebral amyloid angiopathy and macular degeneration
10/13/2011	US20110250259 Method of treating and preventing breast diseases and breast cancer with medicated formula
10/13/2011	US20110250258 Tumor-specific delivery of therapeutic agents via liposomase
10/13/2011	US20110250257 Fibrous tissue sealant and method of using same
10/13/2011	US20110250256 Dissolvable Nano Web Porous Film and Method of Preparing the Same
10/13/2011	US20110250247 Tabletting of erythritol
10/13/2011	US20110250245 Use of stinging cells/capsules for the delivery of active agents to keratinous substances
10/13/2011	US20110250244 Melt-coated pharmaceutical composition with fast release
10/13/2011	US20110250243 Nanoparticle compositions
10/13/2011	US20110250242 Arformoterol and tiotropium compositions and methods for use
10/13/2011	US20110250241 Injection-moulded water-soluble container
10/13/2011	US20110250240 Immune enhancing compositions and methods of use thereof
10/13/2011	US20110250239 Pharmaceutical and/or cosmetic composition for treating the skin
10/13/2011	US20110250238 System for the colon delivery of drugs subject to enzyme degradation and/or poorly absorbed in the gastrointestinal tract
10/13/2011	US20110250237 Immunogenic amphipathic peptide compositions
10/13/2011	US20110250236 Stem cells derived from the carotid body and uses thereof
10/13/2011	US20110250152 Anti-Microbial Dental Formulations for the Prevention and Treatment of Oral Mucosal Disease
10/13/2011	US20110250150 Multi-Part Kit Comprising A Chewing Gum And Further A Flavor Containing Formulation
10/13/2011	US20110250149 Tiotropium Bromide Having a Low Degree of Crystallinity
10/13/2011	US20110250147 Method and System for Reducing Skin Friction
10/13/2011	US20110250134 Sustained release nitric oxide from long lived circulating nanoparticles
10/13/2011	US20110247613 Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
10/13/2011	DE102010014113A1 Freisetzungsverfahren für Implantate Release method for implants
10/13/2011	DE102010003711A1 Verfahren zur Herstellung kristalliner Wirkstoffpartikel Process for preparing crystalline particles of active substance
10/13/2011	CA2832436A1 Controlled release pharmaceutical compositions of tapentadol
10/13/2011	CA2796045A1 Combinations of preservatives for ophthalmic compositions
10/13/2011	CA2796041A1 Combinations of preservative compositions for ophthalmic formulations
10/13/2011	CA2795804A1 Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereof
10/13/2011	CA2795748A1 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
10/13/2011	CA2795746A1 Miniature ingestible device
10/13/2011	CA2795706A1 Sustained-release reservoir implants for intracameral drug delivery
10/13/2011	CA2795699A1 Punctal plugs for controlled release of therapeutic agents
10/13/2011	CA2795334A1 Agent for prophylactic and therapeutic treatment of herpes infections
10/13/2011	CA2795195A1 Thermally stable oil-in-water emulsions containing an oil that contains polyunsaturated fatty acids
10/13/2011	CA2794328A1 Compositions and methods for improved retention of a pharmaceutical composition at a local administration site
10/13/2011	CA2788732A1 Easily dosable solid preparation
10/12/2011	EP2374825A1 Photodynamic therapeutic agent showing accumulation of cell-specific functions
10/12/2011	EP2374535A1 Method and devices for vesicle formation, in particular using block copolymers
10/12/2011	EP2374479A2 Controlled-release composition for producing sustained-release preparation containing udenafil
10/12/2011	EP2374478A1 Nsaids-induced gastrointestinal mucosal disorder alleviator and manufacturing method thereof
10/12/2011	EP2374461A1 Piroxicam for prophylactic and therapeutic treatment of herpes infections
10/12/2011	EP2374460A1 Pulsed-release sildenafil composition and method for preparing said composition
10/12/2011	EP2374457A1 Antihypertensive pharmaceutical composition
10/12/2011	EP2374450A1 Flupentixol compositions
10/12/2011	EP2374449A2 Composition including at least one aqueous phase and at least one oil phase including ivermectin
10/12/2011	EP2374448A1 Oral film formulation
10/12/2011	EP2373350A2 Encapsulating system for cest imaging with chelate q greater than or equal to 2
10/12/2011	EP2373348A1 Delivery system for delivery of a substance into the oral cavity
10/12/2011	EP2373321A1 Platelets lysate and bioadesive compositions thereof for the treatment of mucositis
10/12/2011	EP2373319A2 Sustained release pharmaceutical composition of quetiapine and process for preparation thereof
10/12/2011	EP2373306A1 Transdermally administered aliskiren
10/12/2011	EP2373304A1 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
10/12/2011	EP2373303A1 1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases
10/12/2011	EP2373300A1 Transdermal systems containing multilayer adhesive matrices to modify drug delivery
10/12/2011	EP2373299A2 A microencapsulation process of sertoli cells, microcapsules obtained and their use for prevention and cure of type 1 diabetes mellitus
10/12/2011	EP2373298A1 Compound, medicament, vaccine composition and nanocapsules
10/12/2011	EP2373297A1 Tamsulosin pellets for fixed dose combination
10/12/2011	EP2373296A2 Formulations of guanylate cyclase c agonists and methods of use
10/12/2011	EP2373295A2 Steroidal compositions
10/12/2011	EP2373294A1 Clostridial toxin pharmaceutical compositions
10/12/2011	EP2373293A2 Compositions with reduced dimer formation
10/12/2011	EP2373292A1 Inflammation targeting particles
10/12/2011	EP2373291A1 Process of cracking biofeeds using high zeolite to matrix surface area catalysts
10/12/2011	EP2373290A1 Shelf stable capsules
10/12/2011	EP2373289A2 Stable perfluorocarbon emulsion for use as an artificial oxygen carrier
10/12/2011	EP2373288A2 A novel dermaceutical cream made using sodium fusidate
10/12/2011	EP2373287A1 Extrudate having spicular active substances
10/12/2011	EP2373179A1 Multi-part kit
10/12/2011	EP1965853B1 Device for controlled release of chemical molecules
10/12/2011	EP1804855B1 Flow regulator
10/12/2011	EP1742621B2 Agent-releasing system comprising an agent-containing patch and at least one means regulating the release of agents
10/12/2011	EP1566167B1 Base for oral composition and oral composition
10/12/2011	EP1525884B1 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
10/12/2011	EP1430098B1 Gel matrix consisting of polyacrylic acid and polyvinyl pyrrolidone
10/12/2011	EP1221851B2 Antiviral compositions for tissue paper
10/12/2011	CN202005899U Double-circular-table angle-lap-shaped traditional Chinese medicine tablet with wrapper for treating inflammation of mouth cavity and throat part
10/12/2011	CN1981803B Chinese-medicinal composition for preventing cardiovascular diseases and its production
10/12/2011	CN1980638B Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids
10/12/2011	CN1953770B X-ray visible drug delivery device

1 ... 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 ... 2991